Literature DB >> 24122167

Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction.

Harsh Chauhan, Anuj Kuldipkumar, Timothy Barder, Ales Medek, Chong-Hui Gu, Eman Atef.   

Abstract

PURPOSE: To correlate the polymer's degree of precipitation inhibition of indomethacin in solution to the amorphous stabilization in solid state.
METHODS: Precipitation of indomethacin (IMC) in presence of polymers was continuously monitored by a UV spectrophotometer. Precipitates were characterized by PXRD, IR and SEM. Solid dispersions with different polymer to drug ratios were prepared using solvent evaporation. Crystallization of the solid dispersion was monitored using PXRD. Modulated differential scanning calorimetry (MDSC), IR, Raman and solid state NMR were used to explore the possible interactions between IMC and polymers.
RESULTS: PVP K90, HPMC and Eudragit E100 showed precipitation inhibitory effects in solution whereas Eudragit L100, Eudragit S100 and PEG 8000 showed no effect on IMC precipitation. The rank order of precipitation inhibitory effect on IMC was found to be PVP K90 > Eudragit E100 > HPMC. In the solid state, polymers showing precipitation inhibitory effect also exhibited amorphous stabilization of IMC with the same rank order of effectiveness. IR, Raman and solid state NMR studies showed that rank order of crystallization inhibition correlates with strength of molecular interaction between IMC and polymers.
CONCLUSIONS: Correlation is observed in the polymers ability to inhibit precipitation in solution and amorphous stabilization in the solid state for IMC and can be explained by the strength of drug polymer interactions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24122167     DOI: 10.1007/s11095-013-1178-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions.

Authors:  Gavin P Andrews; Osama Abu-Diak; Febe Kusmanto; Peter Hornsby; Zhai Hui; David S Jones
Journal:  J Pharm Pharmacol       Date:  2010-11       Impact factor: 3.765

2.  Characterisation of the thermal, spectroscopic and drug dissolution properties of mefenamic acid and polyoxyethylene-polyoxypropylene solid dispersions.

Authors:  Gavin P Andrews; Hui Zhai; Simon Tipping; David S Jones
Journal:  J Pharm Sci       Date:  2009-12       Impact factor: 3.534

Review 3.  Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

Authors:  Joachim Brouwers; Marcus E Brewster; Patrick Augustijns
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

4.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

5.  Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.

Authors:  Osama A Abu-Diak; David S Jones; Gavin P Andrews
Journal:  J Pharm Sci       Date:  2011-09-08       Impact factor: 3.534

6.  An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations.

Authors:  Osama A Abu-Diak; David S Jones; Gavin P Andrews
Journal:  Mol Pharm       Date:  2011-07-01       Impact factor: 4.939

7.  Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.

Authors:  Rina J Chokshi; Navnit H Shah; Harpreet K Sandhu; Ahmad W Malick; Hossein Zia
Journal:  J Pharm Sci       Date:  2008-06       Impact factor: 3.534

8.  Kinetic study of catechin stability: effects of pH, concentration, and temperature.

Authors:  Na Li; Lynne S Taylor; Mario G Ferruzzi; Lisa J Mauer
Journal:  J Agric Food Chem       Date:  2012-12-14       Impact factor: 5.279

9.  Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.

Authors:  M Savolainen; K Kogermann; A Heinz; J Aaltonen; L Peltonen; C Strachan; J Yliruusi
Journal:  Eur J Pharm Biopharm       Date:  2008-06-12       Impact factor: 5.571

10.  Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability.

Authors:  Bin Li; Stephanie Konecke; Kim Harich; Lindsay Wegiel; Lynne S Taylor; Kevin J Edgar
Journal:  Carbohydr Polym       Date:  2012-12-03       Impact factor: 9.381

View more
  4 in total

1.  3D Printed "Starmix" Drug Loaded Dosage Forms for Paediatric Applications.

Authors:  Nicolaos Scoutaris; Steven A Ross; Dennis Douroumis
Journal:  Pharm Res       Date:  2018-01-16       Impact factor: 4.200

2.  Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.

Authors:  Derek S Frank; Adam J Matzger
Journal:  Mol Pharm       Date:  2018-06-20       Impact factor: 4.939

3.  Formulation Development, Process Optimization, and In Vitro Characterization of Spray-Dried Lansoprazole Enteric Microparticles.

Authors:  Chintan Vora; Riddhish Patadia; Karan Mittal; Rajashree Mashru
Journal:  Sci Pharm       Date:  2015-07-29

4.  Stabilizing Effect of Soluplus on Erlotinib Metastable Crystal Form in Microparticles and Amorphous Solid Dispersions.

Authors:  Shuyu Jia; Shangqi Ning; Yuting Leng; Qiufang Jing; Zhongyu Xu; Fuzheng Ren
Journal:  Polymers (Basel)       Date:  2022-03-19       Impact factor: 4.329

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.